Mural Oncology (MURA)
NASDAQ: MURA
· Real-Time Price · USD
2.08
0.01 (0.48%)
At close: Aug 22, 2025, 3:59 PM
2.08
0.00%
After-hours: Aug 22, 2025, 07:26 PM EDT
Mural Oncology Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
Net Income | -147.15M | -130.73M | -128.51M | -153.78M | -173.3M | -191.9M | -207.45M | -196.49M | -195.86M | -145.69M | -99.23M | -50.64M |
Depreciation & Amortization | 3.76M | 3.52M | 3.51M | 3.26M | 3.14M | 2.88M | 2.57M | 2.45M | 2.04M | 1.4M | 869K | 372K |
Stock-Based Compensation | 1.08M | 3.4M | 5.08M | 19.65M | 21.6M | 23.55M | 24.11M | 12.07M | 12.57M | 9.43M | 6.68M | 3.48M |
Other Working Capital | 6.08M | -3.35M | -11.54M | -9.83M | -13.51M | -14.04M | -13.48M | -7.44M | -4.49M | -5.55M | 7M | n/a |
Other Non-Cash Items | -1.42M | -9.31M | -9.21M | 6.86M | 14.09M | 16.46M | 20.27M | 8M | 8M | 8M | 4.19M | n/a |
Deferred Income Tax | n/a | n/a | n/a | -16.46M | -16.46M | -16.46M | -16.46M | -4.19M | -4.19M | -4.19M | -4.19M | n/a |
Change in Working Capital | 13.72M | 5.13M | 591K | 966K | -8.97M | -10.39M | -13.48M | -7.44M | 5M | 3.94M | 16.5M | 9.49M |
Operating Cash Flow | -130.01M | -128M | -128.54M | -139.5M | -159.89M | -175.85M | -194.25M | -189.41M | -176.24M | -130.92M | -75.19M | -37.3M |
Capital Expenditures | -52K | -47K | -92K | -1.25M | -2.4M | -3.11M | -3.45M | -2.42M | -3.95M | -3.24M | -2.84M | -2.7M |
Cash Acquisitions | 847K | 67K | 67K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -23.5M | -42.82M | -167.31M | -167.47M | -143.8M | -124.48M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 108M | 170M | 142M | 106M | 63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 85.29M | 127.2M | -25.33M | -62.72M | -83.2M | -127.59M | -3.45M | -2.42M | -3.95M | -3.24M | -2.84M | -2.7M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 315.01M | 366.65M | 412.68M | 468.81M | 191.83M | 180.19M | 134.16M | 78.02M | 39.99M |
Financial Cash Flow | 224K | 224K | 196K | 315.21M | 366.65M | 412.68M | 468.81M | 191.83M | 180.19M | 134.16M | 78.02M | 39.99M |
Net Cash Flow | -44.49M | -581K | -155.39M | 111.28M | 121.84M | 107.52M | 271.11M | n/a | n/a | n/a | n/a | n/a |
Free Cash Flow | -130.06M | -128.05M | -128.64M | -140.75M | -162.29M | -178.96M | -197.7M | -191.83M | -180.19M | -134.16M | -78.02M | -39.99M |